India, July 11 -- For diabetes patients, who require daily insulin dosages, a revolutionary injection which has to be administered only once a week has entered the Indian market. Novo Nordisk India has launched Awiqli for adults with type 1 and type 2 diabetes. Bringing down the burden of annual injections, from 365 to just 52, this may change the way diabetes care is approached. We speak to endocrinologist Dr Anima Sharma about how it works, how it differs from daily injections, and who may benefit from it....